Molina Healthcare (MOH) is expected to announce its first-quarter earnings, with analysts forecasting a return to profitability after a challenging previous quarter. The company faces scrutiny over its Medicaid business's elevated medical loss ratios and ongoing pressures in the Medicare Advantage segment. Investors will be keenly watching management's outlook for Medicaid margin recovery and any guidance provided at the upcoming investor day.

Oppenheimer has lowered its price target for International Flavors & Fragrances (NYSE:IFF) to $88.00 from $97.00, while maintaining an "outperform" rating. This adjustment comes after IFF missed its Q4 EPS estimates and reported a 6.6% year-over-year revenue decrease. Despite the lowered target, an insider, Paul J. Fribourg, recently purchased 142,000 shares, indicating confidence in the company.

Goldman Sachs is offering $10 million in Callable Fixed Rate Notes due October 22, 2030, paying 5.00% annual interest. The company retains the option to redeem these notes quarterly starting October 22, 2026. These notes are issued at 100% of principal with an underwriting concession of up to 0.15% and are subject to FATCA withholding rules.

Axe Compute Inc. (AGPU) saw its stock jump nearly 96% after announcing a 36-month, $260 million enterprise infrastructure contract to deliver 2,304 NVIDIA B300 GPUs. This significant deal, structured with take-or-pay payments, suggests a substantial increase in booked revenue visibility for the company's "neocloud" model. Hedge funds have shown increased interest, with 15 institutional investors adding AGPU shares in the last quarter.

Uber Eats has partnered with Coco Robotics to launch autonomous, zero-emission robot food deliveries in downtown San Jose, California, effective April 22, 2026. Coco's robots, which have completed over 500,000 deliveries, will serve the city's core, aiming to assist restaurants with efficient order fulfillment and provide customers with fast, reliable, and environmentally friendly delivery options. This initiative expands Uber's automation strategy across urban markets and leverages Coco's extensive operational data for rapid adaptation and scaling.

Globe Life Inc. is set to announce its first-quarter earnings, which will be a critical indicator of its ability to meet the ambitious full-year guidance raised just two months ago. Analysts anticipate earnings of $3.48 per share on $1.56 billion in revenue, with a focus on normalizing mortality trends, the growth of its exclusive agent force, and consistent execution towards its full-year targets. The company's stock currently trades at a forward P/E ratio of 9.8, below historical norms, despite analysts projecting a 15.2% return on equity for 2026.

Representative Maria Elvira Salazar purchased Amgen stock valued between $221,025 and $865,000 on March 24, 2026, as per a report filed on April 21, 2026. This transaction is part of her active trading history, which includes 44 stock transactions totaling over $3.42 million in the last three years. Congressional transactions like these are publicly disclosed under the STOCK Act and can offer insights for investors, though they should not be the sole basis for investment decisions.

Lamb Weston Holdings, Inc. has released its latest Global Sustainability Report for fiscal year 2025, detailing progress toward its 2033 sustainability goals. The report highlights achievements in employee and community support, food quality and safety, and environmental stewardship, including reductions in injury rates and freshwater use, and increased recycling. Sylvia Wilks, chief supply chain officer, emphasized the company's commitment to measurable, value-driven sustainability efforts for its business, customers, and team members.

Otis Worldwide reported a 1% increase in total organic sales for Q1 2026, driven by a 5% growth in its service segment, with maintenance and repair sales increasing by 4% and modernization orders up by 11%. The company announced a 5% increase in its quarterly dividend and completed $400 million in share repurchases, reflecting its commitment to returning cash to shareholders. Despite challenges in China, Otis Worldwide saw a strong demand in the Americas with orders growing more than 20%, contributing to a backlog approaching $20 billion, and expects net sales of $15.1 to $15.3 billion for 2026.

Elevance Health exceeded first-quarter expectations with adjusted diluted EPS of $12.58, driven by favorable claims, ACA seasonality, and non-recurring investment income. The company raised its full-year 2026 EPS guidance to at least $26.75 and anticipates at least 12% adjusted EPS growth in 2027. Strategic efforts include integrating AI for member engagement and cost management, and advancing its integrated whole health approach through Carelon, which has shown success in reducing hospital readmissions and generating savings.